-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 19, a media briefing session on Lianhua Qingwen Capsules for the prevention and treatment of new coronavirus pneumonia was held, at which the latest research progress of Lianhua Qingwen capsules/granules in the prevention and treatment of new coronary pneumonia was released
Gathering famous prescriptions from the three dynasties to play an active role in the prevention and control of the world epidemic
At the meeting, Professor Jia Zhenhua from the State Key Laboratory of Collateral Disease Research and Innovative Traditional Chinese Medicine gave a report entitled "Give full play to the advantages of traditional Chinese medicine and play a greater role in the prevention and control of the Omicron epidemic"
Professor Jia Zhenhua from the State Key Laboratory of Collateral Disease Research and Innovative Traditional Chinese Medicine gave a report titled "Give full use of the advantages of traditional Chinese medicine to play a greater role in the prevention and control of the Omicron epidemic"
Lianhua Qingwen has obtained definite clinical research evidence for the prevention and treatment of new coronary pneumonia
Since the outbreak of COVID-19, Lianhua Qingwen capsules/granules have been widely used and played an important role in domestic epidemic prevention and control
New crown pneumonia is preventable and curable, and reliable evidence is obtained
Professor Hou Yunlong from the State Key Laboratory of Collateral Disease Research and Innovative Traditional Chinese Medicine gave a report titled "Basic Research on the Prevention and Treatment of Viral Respiratory Diseases with Chinese Medicine Lianhua Qingwen"
Professor Hou Yunlong of the State Key Laboratory of Collateral Disease Research and Innovative Traditional Chinese Medicine pointed out in a report titled "Basic Research on the Prevention and Treatment of Viral Respiratory Diseases with Traditional Chinese Medicine Lianhua Qingwen", starting from the outbreak in Wuhan, the focus on Lianhua Qingwen's anti-new coronavirus A series of basic and clinical research has been carried out
Professor Yuan Yadong from the Second Hospital of Hebei Medical University made a report entitled "Study on the preventive effect of Lianhua Qingwen Capsule on close contacts of new coronavirus pneumonia"
Professor Yuan Yadong from the Second Hospital of Hebei Medical University introduced the real-world research situation of "Lianhua Qingwen Capsules for the Prevention of Novel Coronavirus Pneumonia" in a report titled "Research on the Prevention Effect of Lianhua Qingwen Capsules on New Coronary Virus Pneumonia Close Contacts"
At present, under the new situation that the mutant strain of Omicron is impacting our country, it is of great practical significance to make good use of Chinese patent medicine to carry out mass prevention and treatment